CTOs on the Move

Bristol-Myers Squibb

www.bms.com

 
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. Our medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others. Through the Bristol-Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world`s most vulnerable people. Each day, our employees around the world work together for patients – it drives everything we do.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.bms.com
  • 345 Park Avenue
    New York, NY USA 10154
  • Phone: 212.546.4000

Executives

Name Title Contact Details
Staci Hargraves
SVP, Head of Transformation, Drug Development Profile
Ami Mehta
Associate Director, IT Lead for Cell Therapy Medical Affairs/Ex US Commercial Profile
Rosimar Lehr
Associate Director, Contract Lead, IT Services, Agile Sourcing Profile
Michael Morris
Executive Director, Global Procurement IT Profile
Ari Hamalian
Executive Director IT Risk Operations and Supplier Resilience Profile

Jobs

Head of Global Talent Acquisition

Bristol-Myers Squibb Princeton, NJ
Job Description

The Head Global Talent Acquisition will report to the Head of Global Talent and Organizational Effectiveness who reports to the company’s Chief Human Resources Officer. The incumbent will lead a global team of 30+ BMS individuals and 110+ recruitment professionals working for Cielo (US) and Alexander Mann ...

Funding

Bristol-Myers Squibb raised $20.2M on 12/17/2020

Similar Companies

Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical corporation based in Indianapolis, Indiana, with a history of nearly 150 years. Founded in 1876 by Colonel Eli Lilly, the company has grown to become one of the largest pharmaceutical enterprises in the world, employing over 42,900 people as of 2023. Lilly focuses on biomedical research, drug discovery, and manufacturing, with a diverse portfolio that includes treatments for diabetes, oncology, neuroscience, and immunology. Lilly pioneered the first commercially available insulin product in 1923 and continues to innovate with modern offerings like Trulicity and Mounjaro for diabetes management. The company also develops drugs such as Verzenio for breast cancer and Zyprexa for psychiatric disorders. With a strong emphasis on research and development, Lilly is recognized for its commitment to improving drug accessibility and patient care through partnerships with healthcare providers and systems worldwide.

Immune Control

Immune Control is a West Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delinia

Delinia has assembled a leadership team, Board of Directors and Scientific Advisory Board comprised of experienced investors, world-class academicians and industry veterans with proven track records for building exceptional life sciences companies.

Exscientia

Exscientia is a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster. Our mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with experimental innovation, to enable the design of patient centric drug candidates with an improved probability of success. Our validated platform has delivered the first three AI-designed drugs to enter clinical trials and is the first AI system proven to improve clinical outcomes in oncology. We`ve significantly accelerated pre-clinical drug discovery, with 10x productivity improvement in delivering a drug candidate compared with industry standards. By actively applying AI to precision engineer medicines more rapidly and efficiently, we allow the best ideas of science to rapidly become the best medicines for patients.

Teewinot Life Sciences Corp

Teewinot Life Sciences is a global biopharmaceutical company focused on the biosynthetic production of pure pharmaceutical grade cannabinoids. Teewinot has developed patent protected processes for production of pure cannabinoids by means of biocatalysis and synthetic biology. Teewinot has also developed patent protected cannabinoid formulation technology all with the goal of improving human therapies. Headquartered in Tampa, Florida, Teewinot manufactures and licenses technology to make cost-effective and pharmaceutically pure cannabinoids. We are an industry leader in support of advancing medical research and product development. Teewinot`s global technology and intellectual property represent a breakthrough in the creation and delivery of cannabinoid-based medicines.